PetCaseFinder

Peer-reviewed veterinary case report

Predicting spread of diffuse iris melanoma in cats from tissue tests

By Wiggans, K Tomo et al.·Published in Veterinary ophthalmology·2016·William R. Pritchard Veterinary Medical Teaching Hospital, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Histologic and immunohistochemical predictors of clinical behavior for feline diffuse iris melanoma.

Species:
cat

Plain-English summary

A study looked at 47 cats with diffuse iris melanoma, a type of eye cancer, that had their eyes removed due to the disease. After surgery, about 19% of these cats developed metastasis, meaning the cancer spread to other parts of their bodies. Certain factors, like the presence of necrosis (dead tissue) in the tumor and high levels of specific proteins, were linked to a higher risk of cancer spreading. The researchers suggest that these factors could help veterinarians identify which cats are at greater risk after surgery.

People also search for: cat eye cancer prognosis · feline diffuse iris melanoma treatment · signs of cat cancer spreading

Abstract

OBJECTIVE: To determine histologic and immunohistochemical predictors of metastasis of feline diffuse iris melanoma (FDIM). ANIMALS: Globes from 47 client-owned cats enucleated for FDIM between January 1985 and December 2013. PROCEDURES: Hematoxylin and eosin-stained sections were evaluated for neoplastic invasiveness and cell morphology, necrosis within the neoplasm, inflammation, and glaucoma. Sections were immunolabeled with antibodies against melan-A, PNL2, E-cadherin, or B-Raf, and label intensity, percentage of labeled cells, and label homogeneity were semi-quantitatively graded. Medical records were evaluated, and referring veterinarians and clients were contacted to determine whether cats developed metastasis following enucleation. The log-rank test or Cox proportional hazards model was used to determine associations between histologic or immunohistochemical parameters and metastasis. RESULTS: Metastasis was suspected or confirmed in 9/47 (19%) cats. Extrascleral extension, necrosis within the neoplasm, a mitotic index of >7 mitoses in 10 high-power (×400) fields, choroidal invasion, and increased E-cadherin and melan-A label intensity were each associated with increased rate of metastasis. PNL2 label homogeneity was associated with decreased rate of metastasis. Decreased PNL2 label intensity and an increasing percentage of neoplastic cells labeled for melan-A each approached significance for increased rate of metastasis. CONCLUSIONS: We report four histologic and three immunohistochemical parameters helpful in determining cats at risk of metastasis of FDIM. Further studies should determine if B-Raf mutations identified in human malignant melanomas are found in cats with FDIM and assess benefits of adjunctive therapy following enucleation of eyes with FDIM bearing poor prognostic indicators.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26805705/